Day: September 11, 2020

ALPHARETTA, Ga., Sept. 11, 2020 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today that its licensing partner, Aura Biosciences, has dosed the first patient in its Phase 2 clinical trial evaluating the safety and efficacy of suprachoroidal administration of AU-011 as a potential first-line treatment for patients with primary choroidal melanoma. Aura is using Clearside’s SCS Microinjector® to deliver AU-011 into the suprachoroidal space (SCS®).Aura also announced that AU-011 passed the Safety Review for the first dose escalation cohort which demonstrated favorable safety data with no safety findings and no adverse events noted. Aura’s preclinical...

NEW YORK, Sept. 11, 2020 (GLOBE NEWSWIRE) — Ascendant Digital Acquisition Corp. (NYSE: ACND.U) (the “Company”) today announced that, commencing September 14, 2020, holders of the units sold in the Company’s initial public offering may elect to separately trade the Company’s Class A ordinary shares and warrants included in the units.No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The Class A ordinary shares and warrants that are separated will trade on the New York Stock Exchange under the symbols “ACND” and “ACND WS,” respectively. Those units not separated will continue to trade on the New York Stock Exchange under the symbol “ACND.U.” Holders of units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Company’s transfer agent, in order...

TORONTO, Sept. 11, 2020 (GLOBE NEWSWIRE) — CR Capital Corp. (TSX-V / CIT) (“CR Capital” or the “Company“) is pleased to announce that the results from its July 2020 surface rock and soil geochemical sampling program are available for the Glenrock Gold Property (“Property”) located 100 km north of Sault Ste. Marie, Ontario.  The Property consists of 109 cell claims totaling approximately 1,800 hectares and is contiguous to the southeast with the larger Coppercorp Property also held 100% by CR Capital. The exploration program was undertaken in follow-up to the results of the sampling program reported in the January 13, 2020 News Release. During the program, the work focus was on the further assessment of the Glenrock West gold showing area for which 24 rock samples were obtained from outcrop or subcrop and...

CHARLOTTE, N.C., Sept. 11, 2020 (GLOBE NEWSWIRE) — Extended Stay America, Inc. and its paired-share REIT, ESH Hospitality, Inc. (together, the “Company”) (NASDAQ:STAY), the largest mid-priced extended stay hotel brand, today announced that David Clarkson has been appointed Chief Financial Officer, effective September 11, 2020. Mr. Clarkson will succeed Brian Nicholson, who has resigned from the Chief Financial Officer role effective immediately to pursue other interests.  Mr. Nicholson will continue with STAY in a consulting role until February 26, 2021 to assist with the transition.  Mr. Nicholson’s resignation is not related to any issues involving the Company’s operations, financial statements, internal controls, policies or practices.Mr. Clarkson brings more than 25 years of corporate finance experience to the Company. ...

SAN FRANCISCO, Sept. 11, 2020 (GLOBE NEWSWIRE) — Stitch Fix, Inc. (NASDAQ: SFIX), the leading online personal styling service, today announced that Katrina Lake, founder and CEO of Stitch Fix, is scheduled to participate in a virtual fireside chat at the KeyBanc Capital Markets Future of Technology Series on Friday, September 25 at 8:30 A.M. PT / 11:30 A.M. ET.A live webcast and replay of the session will be available on the investor relations section of the Stitch Fix website at https://investors.stitchfix.com.About Stitch FixStitch Fix is an online personal styling service that is reinventing the shopping experience by delivering one-to-one personalization to our clients through the combination of data science and human judgment. Stitch Fix was founded in 2011 by CEO Katrina Lake. Since then, we’ve helped millions of women, men,...

BROOKFIELD NEWS, Sept. 11, 2020 (GLOBE NEWSWIRE) — Brookfield Property Partners L.P. (“BPY”) (NASDAQ: BPY; TSX: BPY.UN) announced today that the Toronto Stock Exchange (the “TSX”) accepted a notice filed by BPY of its intention to renew its prior normal course issuer bid for a one-year period. BPY stated that at times its limited partnership units trade in price ranges that do not fully reflect their value. As a result, from time to time, acquiring limited partnership units represents a desirable use of available funds.The notice provides that BPY may, during the twelve-month period commencing September 15, 2020 and ending September 14, 2021, purchase on the TSX, the Nasdaq Stock Market (“Nasdaq”) and any alternative Canadian or U.S. trading system, up to 31,602,923 limited partnership units, representing approximately 10% of its...

First potentially disease-modifying, anti-alpha-synuclein antibody to demonstrate signals of efficacy on multiple pre-specified secondary and exploratory clinical endpoints, including measures of motor function and biomarkers, in patients with early Parkinson’s diseaseSignificantly reduced decline in motor function by 35% vs. placebo at one year and delayed time to clinically meaningful worsening of motor progression over one yearResults support further clinical development of prasinezumabInvestor webcast scheduled for Tuesday, September 15 at 1:30PM ET following Top Abstract oral presentation at the MDS Virtual Congress 2020DUBLIN, Ireland, Sept. 11, 2020 (GLOBE NEWSWIRE) — Prothena Corporation plc (NASDAQ:PRTA), announced that results from the Phase 2 PASADENA study of prasinezumab are being highlighted today at the International...

New data from ongoing Phase 3 study further define the effectiveness and improved GI tolerability of VUMERITY® (diroximel fumarate)Real-world findings evaluate quality of life benefits associated with TYSABRI® (natalizumab) when compared to Ocrevus®(ocrelizumab)Additional real-world findings report positive benefits of PLEGRIDY® (peginterferon beta-1a) and AVONEX® (interferon beta-1a) in older individuals with relapsing multiple sclerosisCAMBRIDGE, Mass., Sept. 11, 2020 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) today announced new data underscoring the efficacy and safety of its broad, industry-leading portfolio of multiple sclerosis (MS) therapies. These data will be presented during MSVirtual2020, the eighth joint meeting of the Americas Committee for Treatment and Research in Multiple Sclerosis and the European Committee...